Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $75.54, giving the company a market capitalization of 7.94B. It carries a P/E multiple of 86.55.
On 2025-11-15, Corcept Therapeutics(CORT) stock moved within a range of $74.12 to $76.62. With shares now at $75.54, the stock is trading +1.9% above its intraday low and -1.4% below the session's peak.
Trading volume for Corcept Therapeutics(CORT) stock has reached 369.27K, versus its average volume of 741.46K.
The stock's 52-week range extends from a low of $49.00 to a high of $117.33.
The stock's 52-week range extends from a low of $49.00 to a high of $117.33.
CORT News
Corcept Therapeutics (CORT) posted its third-quarter results, highlighting revenue growth fueled by new Korlym prescriptions. However, revenue and net income we...
